ZURA
NASDAQ · Biotechnology
Zura Bio Ltd
$1.43
+0.03 (+1.78%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,516.8% upside
Low Target
$15.51
Average Target
$23.12
High Target
$31.84
Current Price
$1.43
Current
$1.43
$1.43
Target
$23.12
$23.12
$15.51
$23.12 avg
$31.84
Scenario Analysis
Bear Case
$15.51
984.6%
Low target
Base Case
$23.12
+1,516.8%
Avg target
Bull Case
$31.84
+2,126.6%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$7.44
-80.8% from high
52-Week Low
$3.25
+-56.0% from low
Target vs 52W High
$23.12
+210.8% vs high
Next Earnings Report
Nov 18, 2026
4d
until earnings
EPS Est: $-0.21
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |